跳至主要内容
临床试验/NCT00898066
NCT00898066已完成不适用

Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma

SWOG Cancer Research Network0 个研究点目标入组 37 人开始时间: 2005年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
37
主要终点
Frequency of deletion 13 as detected by fluorescence in situ hybridization (FISH) and conventional cytogenetics

研究概览

简要总结

RATIONALE: Studying the chromosomes in samples of bone marrow and blood in the laboratory from patients with cancer or other blood diseases may help doctors learn more about the disease.

PURPOSE: This laboratory study is analyzing chromosomes in patients with newly diagnosed multiple myeloma or other blood disease.

详细描述

OBJECTIVES:

  • Compare the frequency of deletion 13 as detected by fluorescence in situ hybridization (FISH) and conventional cytogenetics in patients with newly diagnosed multiple myeloma (MM) or other monoclonal gammopathies (MG).
  • Examine the prognostic value of specific subsets of chromosome aberrations detected by conventional cytogenetics and FISH in relation to event-free and overall survival in these patients.
  • Compare the prognostic value of cytogenetics and FISH with other MM and MG prognostic factors in these patients.
  • Correlate the presence of cytogenetic and FISH features with clinical pathophysiological, cellular, or other molecular characteristics in these patients.

OUTLINE: Patients receive treatment as directed by the treatment clinical trial on which they are registered. Patients undergo bone marrow or blood sample collection periodically for conventional cytogenetic analysis and fluorescence in situ hybridization studies (FISH). Samples are analyzed for deleted 13q/monosomy 13 and chromosomal abnormalities.

PROJECTED ACCRUAL: A total of 500 patients will be accrued for this study.

研究设计

研究类型
Observational

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Frequency of deletion 13 as detected by fluorescence in situ hybridization (FISH) and conventional cytogenetics

时间窗: 1 year

Comparison of prognostic value of cytogenetics and FISH with other multiple myeloma and monoclonal gammopathy prognostic factors

时间窗: 1 year

Correlation between the presence of cytogenetic and FISH features and clinical pathophysiological, cellular, or other molecular characteristics

时间窗: 1 year

Prognostic value of specific subsets of chromosome aberrations detected by conventional cytogenetics and FISH in relation to event-free and overall survival

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

相似试验

S0334 Analyzing Chromosomes in Patients With Newly... | 临床试验